Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Regional Innovation Clusters (RICs), Incubators, Accelerators, Technology Transfer, SBIR/STTR, OTA, Non-Traditionals & Triple Helix
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)

Organization & Developments: InVivo

Parents

2017: InVivo Therapeutics Announces Updates on the INSPIRE Study – InVivo Therapeutics
2018: Is InVivo's Neuro-Spinal Scaffold Back on Track After Halted Trial?
Developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI).
InVivo treatment uses a scaffold made of a biodegradable polymer designed to act as a “synthetic extracellular matrix” and to re
InVivo’s platform technologies focus on minimizing tissue damage sustained following acute injury and promoting neural plasticity of the spared healthy tissue, which may result in full or partial functional recovery.
Neuro-Spinal Scaffold, a device designed to provide structural support for areas of acute spinal injury to help promote the natural healing process.
The technologies encompass multiple strategies involving biomaterials, U.S. Food & Drug Administration (FDA) approved drugs, growth factors, and human neural stem cells (hNSCs).